{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:15:52Z","timestamp":1783646152216,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["21\/2023 \\u2013 Processo 444401\/2023-7"],"award-info":[{"award-number":["21\/2023 \\u2013 Processo 444401\/2023-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.mycmed.2025.101595","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:24:10Z","timestamp":1764001450000},"page":"101595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nitroxoline and its combination with antifungals: An alternative for the treatment of fungal biofilm"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-4928","authenticated-orcid":false,"given":"Jade Andr\u00e9","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Ferreira","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Reginatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella da Rosa Monte","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Meneghello","family":"Fuentefria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2025.101595_bib0001","series-title":"WHO fungal priority pathogens list to guide research, development and public health action","year":"2022"},{"issue":"9","key":"10.1016\/j.mycmed.2025.101595_bib0002","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1017\/ice.2020.156","article-title":"Bacterial and fungal infections in COVID-19 patients: a matter of concern","volume":"41","author":"Zhou","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.mycmed.2025.101595_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2021.101725","article-title":"Impacto da covid-19 na incid\u00eancia, distribui\u00e7\u00e3o de esp\u00e9cies e no progn\u00f3stico das infec\u00e7\u00f5es de corrente sangu\u00ednea por candida","volume":"26","author":"Garnica","year":"2022","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"10.1016\/j.mycmed.2025.101595_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/jof6010021","article-title":"Contributions of the biofilm matrix to Candida pathogenesis","volume":"6","author":"Nett","year":"2020","journal-title":"J Fungi"},{"issue":"8","key":"10.1016\/j.mycmed.2025.101595_bib0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00203-022-03122-2","article-title":"Antimicrobial activity of clioquinol and nitroxoline: a scoping review","volume":"204","author":"Wykowski","year":"2022","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1016\/j.mycmed.2025.101595_bib0006","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijantimicag.2016.04.019","article-title":"In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans","volume":"48","author":"Zuo","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.mycmed.2025.101595_bib0007","first-page":"1","article-title":"Rapid tools to gain insights into the interaction dynamics of new 8- hydroxyquinolines with few fungal lines","volume":"93","author":"Joaquim","year":"2018","journal-title":"Chem Biol Drug Des"},{"issue":"11","key":"10.1016\/j.mycmed.2025.101595_bib0008","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/jac\/dky255","article-title":"Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline","volume":"73","author":"Wijma","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2025.101595_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-014-0628-7","article-title":"Review of the literature and individual patients\u2019 data meta-analysis on efficacy and tolerance of nitroxoline in the 70 treatment of uncomplicated urinary tract infections","volume":"14","author":"Naber","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.mycmed.2025.101595_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/lam.13607","article-title":"8-hydroxyquinoline and quinazoline derivatives as potential new alternatives to combat Candida spp. biofilm","volume":"74","author":"Reginatto","year":"2022","journal-title":"Lett Appl Microbiol"},{"issue":"4","key":"10.1016\/j.mycmed.2025.101595_bib0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/21505594.2015.1039885","article-title":"Synergistic combinations of antifungals and antivirulence agents to fight against Candida albicans","volume":"6","author":"Cui","year":"2015","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.mycmed.2025.101595_bib0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/lam.12820","article-title":"Antifungals discovery: an insight into new strategies to combat antifungal resistance","volume":"66","author":"Fuentefria","year":"2017","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.mycmed.2025.101595_bib0013","unstructured":"BRCAST. Brazilian committee on antimicrobial susceptibility testing. Documento definitivo E.DEF. 7.3.2. 2020."},{"issue":"7","key":"10.1016\/j.mycmed.2025.101595_bib0014","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/pharmaceutics16070957","article-title":"Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of Candida auris","volume":"16","author":"Cavallo","year":"2024","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.mycmed.2025.101595_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00781-24","article-title":"In vitro evaluation of antifungal combinations against neurotropic dematiaceous fungi associated with primary cerebral phaeohyphomycosis","volume":"12","author":"Samaddar","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"8","key":"10.1016\/j.mycmed.2025.101595_bib0016","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","article-title":"Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci","volume":"115","author":"Stepanovi\u0107","year":"2007","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.mycmed.2025.101595_bib0017","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/mmy\/myx003","article-title":"Evaluation of 8-hydroxyquinoline derivatives as hits for antifungal drug design","volume":"55","author":"Pippi","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2025.101595_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105520","article-title":"Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia","volume":"166","author":"Erami","year":"2022","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.mycmed.2025.101595_bib0019","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MOU.0000000000000365","article-title":"The revival of old antibiotics for treatment of uncomplicated urinary tract infections in the era of antibiotic stewardship","volume":"27","author":"Kranz","year":"2017","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1016\/j.mycmed.2025.101595_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02265-21","article-title":"In Vitro Activity of Nitroxoline in Antifungal-Resistant Candida Species Isolated from the Urinary Tract","volume":"66","author":"Fuchs","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mycmed.2025.101595_bib0021","doi-asserted-by":"crossref","first-page":"451","DOI":"10.14740\/jocmr2992w","article-title":"Combination antifungal therapy: a review of current data","volume":"9","author":"Campitelli","year":"2017","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.mycmed.2025.101595_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114874","article-title":"New antifungal strategies: drug combination and co-delivery","volume":"198","author":"Zhu","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.mycmed.2025.101595_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/jof8020100","article-title":"A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era","volume":"8","author":"Thomaz","year":"2022","journal-title":"J Fungi"},{"issue":"7","key":"10.1016\/j.mycmed.2025.101595_bib0024","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1099\/jmm.0.001377","article-title":"8-hydroxyquinoline-5-(N-4-chlorophenyl) sulfonamide and fluconazole combination as a preventive strategy for Candida biofilm in haemodialysis devices","volume":"70","author":"Rocha","year":"2021","journal-title":"J Med Microbiol"},{"issue":"10457","key":"10.1016\/j.mycmed.2025.101595_bib0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(24)01695-7","article-title":"Beyond bacteria: the growing threat of antifungal resistance","volume":"404","author":"Van Rhijn","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mycmed.2025.101595_bib0026","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1099\/jmm.0.000850","article-title":"Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices","volume":"67","author":"Pippi","year":"2018","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2025.101595_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.638609","article-title":"Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition","volume":"12","author":"Atriwal","year":"2021","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.mycmed.2025.101595_bib0028","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/jof9100955","article-title":"Biofilm formation in medically important Candida species","volume":"9","author":"Malinovsk\u00e1","year":"2023","journal-title":"J Fungi"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523325000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523325000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:19:27Z","timestamp":1778591967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523325000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1156523325000587"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2025.101595","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroxoline and its combination with antifungals: An alternative for the treatment of fungal biofilm","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2025.101595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SFMM. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101595"}}